Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 2 Study of the Effect of Zoledronate on Local Recurrence After Surgical Treatment of Giant Cell Tumors of Bone

NCT01564121 is registered in ClinicalTrials.gov with Nantes University Hospital as lead sponsor.

NCT NCT01564121
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01564121 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 2 Study of the Effect of Zoledronate on Local Recurrence After Surgical Treatment of Giant Cell Tumors of Bone
Lead sponsor
Nantes University Hospital
Phase
Phase 1/2
Overall status
Terminated
Start date
January 31, 2006
Completion date
January 31, 2011
Enrollment
24 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

giant cell tumors of bone